Abstract
Purpose
To develop a convolutional neural network (CNN)-based program to analyze maximum intensity projection (MIP) images of 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) positron emission tomography (PET) scans, aimed at predicting lymph node metastasis of non-small cell lung cancer (NSCLC), and to evaluate its effectiveness in providing diagnostic assistance to radiologists.
Methods
We obtained PET images of NSCLC from public datasets, including those of 435 patients with available N-stage information, which were divided into a training set (n = 304) and a test set (n = 131). We generated 36 maximum intensity projection (MIP) images for each patient. A residual network (ResNet-50)-based CNN was trained using the MIP images of the training set to predict lymph node metastasis. Lymph node metastasis in the test set was predicted by the trained CNN as well as by seven radiologists twice: first without and second with CNN assistance. Diagnostic performance metrics, including accuracy and prediction error (the difference between the truth and the predictions), were calculated, and reading times were recorded.
Results
In the test set, 67 (51%) patients exhibited lymph node metastases and the CNN yielded 0.748 predictive accuracy. With the assistance of the CNN, the prediction error was significantly reduced for six of the seven radiologists although the accuracy did not change significantly. The prediction time was significantly reduced for five of the seven radiologists with the median reduction ratio 38.0%.
Conclusion
The CNN-based program could potentially assist radiologists in predicting lymph node metastasis by increasing diagnostic confidence and reducing reading time without affecting diagnostic accuracy, at least in the limited situations using MIP images.
Similar content being viewed by others
Data availability
Raw images and clinical data are available in The Cancer Imaging Archive. Processed images and CNN models are available from the corresponding author on request.
References
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. https://doi.org/10.3322/caac.21708.
Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17:362–87. https://doi.org/10.1016/j.jtho.2021.11.003.
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw Version 12015. 2014;12:1738–61. https://doi.org/10.6004/jnccn.2014.0176.
Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e211S – e250. https://doi.org/10.1378/chest.12-2355.
Schimmer C, Neukam K, Elert O. Staging of non-small cell lung cancer: clinical value of positron emission tomography and mediastinoscopy. Interact Cardiovasc Thorac Surg. 2006;5:418–23. https://doi.org/10.1510/icvts.2006.129478.
Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440–5. https://doi.org/10.1016/j.ejcts.2009.04.003.
Ose N, Sawabata N, Minami M, Inoue M, Shintani Y, Kadota Y, et al. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Eur J Cardiothorac Surg. 2012;42:89–92. https://doi.org/10.1093/ejcts/ezr287.
Wo Y, Li H, Zhang Y, Peng Y, Wu Z, Liu P, et al. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer. Lung Cancer. 2022;170:141–7. https://doi.org/10.1016/j.lungcan.2022.06.018.
Zhao Y, Mao Y, He J, Gao S, Zhang Z, Ding N, et al. Lobe-specific lymph node dissection in clinical stage IA solid-dominant non-small-cell lung cancer: a propensity score matching study. Clin Lung Cancer. 2021;22:e201–10. https://doi.org/10.1016/j.cllc.2020.09.012.
Sadaghiani MS, Rowe SP, Sheikhbahaei S. Applications of artificial intelligence in oncologic 18F-FDG PET/CT imaging: a systematic review. Ann Transl Med. 2021;9:823. https://doi.org/10.21037/atm-20-6162.
Tau N, Stundzia A, Yasufuku K, Hussey D, Metser U. Convolutional neural networks in predicting nodal and distant metastatic potential of newly diagnosed non-small cell lung cancer on FDG PET images. AJR Am J Roentgenol. 2020;215:192–7. https://doi.org/10.2214/AJR.19.22346.
Ouyang ML, Zheng RX, Wang YR, Zuo Z, Gu L, Tian Y, et al. Deep learning analysis using 18F-FDG PET/CT to predict occult lymph node metastasis in patients with clinical N0 lung adenocarcinoma. Front Oncol. 2022. https://doi.org/10.3389/fonc.2022.915871.
Wallis D, Soussan M, Lacroix M, Akl P, Duboucher C, Buvat I. An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients. Eur J Nucl Med Mol Imaging. 2022;49:881–8. https://doi.org/10.1007/s00259-021-05513-x.
Kawauchi K, Furuya S, Hirata K, Katoh C, Manabe O, Kobayashi K, et al. A convolutional neural network-based system to classify patients using FDG PET/CT examinations. BMC Cancer. 2020;20:227. https://doi.org/10.1186/s12885-020-6694-x.
Seeing more with PET scans: scientists discover new chemistry for medical images | Berkeley lab—news center. https://newscenter.lbl.gov/2017/07/27/new-chemistry-pet-scans-medical-imaging/. Accessed 18 Dec 2022
Nishiyama Y, Kinuya S, Kato T, Kayano D, Sato S, Tashiro M, et al. Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017. Ann Nucl Med. 2019;33:725–32. https://doi.org/10.1007/s12149-019-01382-5.
Waller J, O’Connor A, Rafaat E, Amireh A, Dempsey J, Martin C, et al. Applications and challenges of artificial intelligence in diagnostic and interventional radiology. Pol J Radiol. 2022;87:e113–7. https://doi.org/10.5114/pjr.2022.113531.
Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26:1045–57. https://doi.org/10.1007/s10278-013-9622-7.
Machtay M, Duan F, Siegel BA, Snyder BS, Gorelick JJ, Reddin JS, et al. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. J Clin Oncol. 2013;31:3823–30. https://doi.org/10.1200/JCO.2012.47.5947.
Kinahan P, Muzi M, Bialecki B, Herman B, Coombs L. Data from the ACRIN 6668 Trial NSCLC-FDG-PET. The Cancer Imaging Arch. 2019. https://doi.org/10.7937/tcia.2019.30ilqfcl.
Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data–methods and preliminary results. Radiology. 2012;264:387–96. https://doi.org/10.1148/radiol.12111607.
Bakr S, Gevaert O, Echegaray S, et al. Data for NSCLC radiogenomics collection. Cancer Imaging Arch. 2017. https://doi.org/10.7937/K9/TCIA.2017.7hs46erv.
National Cancer Institute clinical proteomic tumor analysis consortium (CPTAC). The clinical proteomic tumor analysis consortium lung squamous cell carcinoma collection (CPTAC-LSCC). 13th version. The Cancer Imaging Arch. 2018. https://doi.org/10.7937/K9/TCIA.2018.6EMUB5L2
National Cancer Institute clinical proteomic tumor analysis consortium (CPTAC). The clinical proteomic tumor analysis consortium lung adenocarcinoma collection (CPTAC-LUAD). 11th version. Cancer Imaging Arch. 2018. https://doi.org/10.7937/K9/TCIA.2018.PAT12TBS
Kirk S, Lee Y, Kumar P, et al. The cancer genome Atlas lung squamous cell carcinoma collection (TCGA-LUSC). 4th version . The Cancer Imaging Arch. 2016. https://doi.org/10.7937/K9/TCIA.2016.TYGKKFMQ
Albertina B, Watson M, Holback C, et al. Radiology Data from the Cancer Genome Atlas Lung adenocarcinoma [TCGA-LUAD] collection. The Cancer Imaging Arch. 2016. https://doi.org/10.7937/K9/TCIA.2016.JGNIHEP5.
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of IEEE comput soc conf comput vis pattern recognit; 2016;2016-December;p. 770–8. https://doi.org/10.1109/CVPR.2016.90
Han Y, Ma Y, Wu Z, et al. Histologic subtype classification of non-small cell lung cancer using PET/CT images. Eur J Nucl Med Mol Imaging. 2020;48(2):350–60. https://doi.org/10.1007/S00259-020-04771-5.
Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: visual explanations from deep networks via gradient-based localization. Int J Comput Vis. 2016. https://doi.org/10.1007/s11263-019-01228-7.
Girum KB, Rebaud L, Cottereau AS, Meignan M, Clerc J, Vercellino L, et al. 18F-FDG PET maximum-intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients. J Nucl Med. 2022;63:1925–32. https://doi.org/10.2967/jnumed.121.263501.
Rodríguez-Ruiz A, Krupinski E, Mordang JJ, Schilling K, Heywang-Köbrunner SH, Sechopoulos I, et al. Detection of breast cancer with mammography: effect of an artificial intelligence support system. Radiology. 2019;290:305–14. https://doi.org/10.1148/radiol.2018181371.
Lebovitz S, Levina N, Lifshitz-Assa H. Is AI ground truth really true? The dangers of training and evaluating AI tools based on experts’ know-what. MIS Q. 2021;45:1501–26. https://doi.org/10.25300/MISQ/2021/16564.
Kelly BS, Judge C, Bollard SM, Clifford SM, Healy GM, Aziz A, et al. Radiology artificial intelligence: a systematic review and evaluation of methods (RAISE). Eur Radiol. 2022;32:7998–8007. https://doi.org/10.1007/s00330-022-08784-6.
Chen L, Zhou Z, Sher D, Zhang Q, Shah J, Pham NL, et al. Combining many-objective radiomics and 3D convolutional neural network through evidential reasoning to predict lymph node metastasis in head and neck cancer. Phys Med Biol. 2019;64: 075011. https://doi.org/10.1088/1361-6560/ab083a.
Leal JP, Rowe SP, Stearns V, Connolly RM, Vaklavas C, Liu MC, et al. Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow. Front Oncol. 2022;12:1007874. https://doi.org/10.3389/fonc.2022.1007874.
Acknowledgements
The results published here are in whole or part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga. We would like to express our sincere gratitude to the five readers, Kanae K. Miake, Tomomi W. Nobashi, Mahoto Juuo, Toshiya Takamura, Daiki Toda, Department of Diagnostic Radiology, Kyoto University Hospital, for their invaluable contributions to this research as participants in the reading experiment.
Funding
This study was financially supported by JSPS KAKENHI (Grant number 22K15879).
Author information
Authors and Affiliations
Contributions
EK: data collection, statistical analysis, drafting of the article. SK: data collection, conception and design, interpretation of data, drafting of this article. KH: conception and design, interpretation of data, revision for important intellectual content. MH: revision for important intellectual content. RN: data collection, revision for important intellectual content. YN: conception and design, final approval of this article. All authors have read and approved the manuscript before submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kidera, E., Koyasu, S., Hirata, K. et al. Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET. Ann Nucl Med 38, 71–80 (2024). https://doi.org/10.1007/s12149-023-01866-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-023-01866-5